^
Association details:
| Biomarker: | EGFR-RAD51 fusion |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | gefitinib (EGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
EGFR-RAD51 gene fusion NSCLC responsiveness to different generation EGFR-TKIs: two cases and review of the literature
Published date:
01/14/2022
Excerpt:
Herein, we report the case of two young non smoker females with metastatic NSCLC harboring EGFR-RAD51 gene fusion...The patient, therefore, started first-line treatment with first-generation EGFR-TKI gefitinib...after three months a CT scan showed a complete response (CR)...
DOI:
https://dx.doi.org/10.21037/tlcr-21-888
